Announcements Trials
Browse Landscape

Status

Unknown 4Recruiting 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 240Carcinoma, Renal Cell 74Urinary Bladder Neoplasms 56Kidney Neoplasms 31Breast Neoplasms 26Neoplasms 25Carcinoma, Transitional Cell 22Neoplasm Metastasis 21Carcinoma, Non-Small-Cell Lung 14Sarcoma 11Non-Muscle Invasive Bladder Neoplasms 11Lung Neoplasms 11Melanoma 10Wilms Tumor 8Testicular Neoplasms 8Colorectal Neoplasms 8Uterine Cervical Neoplasms 7Urologic Neoplasms 7Stomach Neoplasms 7Pancreatic Neoplasms 7Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Recurrence 6Ovarian Neoplasms 6Endometrial Neoplasms 6Carcinoma, Hepatocellular 6Carcinoma 6Prostatic Neoplasms, Castration-Resistant 5Neuroblastoma 5Esophageal Neoplasms 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Muscle Invasive Bladder Cancer × Genitourinary × Clear all
NCT05860543 2024-09-25

Clinical Performance Evaluation of the C2i Test

University of Texas Southwestern Medical Center

Withdrawn
Genitourinary

Muscle Invasive Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡